leading Cancer Precision Medicine

Hangzhou AimingMed Technologies Co., Ltd.

Aiming Medicine Focuses On The Emerging Field Of "Organoid" Technology

AimingMed is a leading biotech company specializing in organoid technology.Our techniques empower oncologist with organoid-based drug sensitivity tests, and our AI algorithm facilitate the selection of the most suitable treatment options for patients.Moreover, we offer drug evaluation models and a high-throughput drug screening platform to pharmaceutical companies, significantly accelerate the new drug development process and optimizing research costs.

Our Team

Chongyang Shen PhD

Chief Executive Officer

Professor Lijuan Wu

Co-founder/Chief Executive Officer of Aiming Medical Laboratory

PhD Huayang Xing

Vice President of R&D

PhD Yi Zhou

Chief Operations Officer

PhD Lee Hong Kai

Chief Information Officer

Our Mission and Vision

Mission

Give directions for heal
Bring hopes for life.

Vision

Leading Cancer Precision
Medicine.

IDEA Values

Innovation

Dedication

Excellence

Achievement